Home > Insider Trading > Filing (0001415889-25-005240)

Filing Details

Accession Number:: 0001415889-25-005240
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-24 16:00:06
Reporting Period:: 2025-02-21

Filing Date:: 2025-02-24
Accepted Time:: 2025-02-24 16:00:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Eli Lilly & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
316011	Lilly Endowment Inc	2801 North Meridian Street Indianapolis IN 46208-0068		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2025-02-21	20,542	$877.31	96,601,320	No	4	S	Direct
Common Stock	Disposition	2025-02-21	9,766	$878.43	96,591,554	No	4	S	Direct
Common Stock	Disposition	2025-02-21	19,490	$879.71	96,572,064	No	4	S	Direct
Common Stock	Disposition	2025-02-21	5,781	$880.35	96,566,283	No	4	S	Direct
Common Stock	Disposition	2025-02-21	2,908	$881.57	96,563,375	No	4	S	Direct
Common Stock	Disposition	2025-02-21	4,079	$882.50	96,559,296	No	4	S	Direct
Common Stock	Disposition	2025-02-21	3,640	$883.43	96,555,656	No	4	S	Direct
Common Stock	Disposition	2025-02-21	5,182	$884.45	96,550,474	No	4	S	Direct
Common Stock	Disposition	2025-02-21	1,221	$885.47	96,549,253	No	4	S	Direct
Common Stock	Disposition	2025-02-21	1,829	$886.44	96,547,424	No	4	S	Direct
Common Stock	Disposition	2025-02-21	2,700	$887.45	96,544,724	No	4	S	Direct
Common Stock	Disposition	2025-02-21	1,087	$888.75	96,543,637	No	4	S	Direct
Common Stock	Disposition	2025-02-21	2,700	$889.99	96,540,937	No	4	S	Direct
Common Stock	Disposition	2025-02-21	7,452	$890.82	96,533,485	No	4	S	Direct
Common Stock	Disposition	2025-02-21	6,152	$891.79	96,527,333	No	4	S	Direct
Common Stock	Disposition	2025-02-21	3,357	$892.78	96,523,976	No	4	S	Direct
Common Stock	Disposition	2025-02-21	1,566	$893.75	96,522,410	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $877.00 to $877.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), and (17) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $878.00 to $878.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $879.00 to $879.9979, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $880.00 to $880.9993, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $881.00 to $881.9999, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $882.00 to $882.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $883.00 to $883.961, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $884.00 to $884.995, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $885.00 to $885.97, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $886.00 to $886.92, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $887.01 to $887.98, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $888.2254 to $889.025, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $889.2983 to $890.2913, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $890.3086 to $891.30, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $891.32 to $892.315, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $892.325 to $893.31, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $893.33 to $894.23, inclusive.